Why the study?
Does prior PTCA reduce adverse cardiac outcomes within 30 days after noncardiac surgery compared to nonrevascularized CAD or normal controls?
Population
Patients ≥45 years old undergoing noncardiac surgery from 1987 to 1993, including those with prior…
Comparison
Prior percutaneous transluminal coronary… vs Nonrevascularized coronary artery disease and…
Design
Cohort
Follow-up
30 days
Authors
Loading...
May inform perioperative risk models incorporating PTCA history; extends observational data but leaves open causal benefit versus untreated CAD.
Does prior PTCA reduce adverse cardiac outcomes within 30 days after noncardiac surgery compared to nonrevascularized CAD or normal controls?
Patients with prior PTCA have a lower risk of adverse cardiac outcomes after noncardiac surgery compared to those with untreated CAD, though their risk remains higher than healthy controls.
Posner et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: